Replay available

MiMedx Group, Inc (MDXG) Q4 2025 Earnings Call

MiMedx Group, Inc (NASDAQ: MDXG) Q4 2025 earnings conference call, held 2026-02-25. Replay captured from the company's public earnings webcast.

Wed, February 25, 2026 at 4:30 PMendedReplay
MiMedx Group, Inc (MDXG) Q4 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Brad Bowers

Analyst at Mizuho Securities

Matt Atariani

Head of Investor Relations

Chase Knickerbocker

Analyst at Craig Allen

Joe Capper

Chief Executive Officer

Doug Rice

Chief Financial Officer

Dave Terkelite

Analyst at Citizens Bank

Replay transcript excerpt

Good afternoon, and thank you for standing by. Welcome to the Memetics fourth quarter and full year 2025 Operating and Financial Results Conference Call. At this time, all participants are in listen-only mode. Question and answer session will follow the formal presentation. As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Mr. Matt Atariani, Head of Investor Relations for Memetics. Thank you, Matt. You may begin. Thank you, Operator, and good afternoon, everyone. Welcome to the MiMedx fourth quarter and full year 2025 Operating and Financial Results Conference call. With me on today's call are Chief Executive Officer Joe Capper and Chief Financial Officer Doug Rice. As part of today's webcast, we are simultaneously displaying slides that you can follow. You can access the slides from the Investor Relations website at MiMedx.com. Joe will kick us off with some opening remarks and a summary of our operating highlights as well as a discussion of the market environment and our financial goals. Next, Doug will provide a review of our financial results for the quarter and full year. Joe will then conclude before we make ourselves available for your questions. Before we begin, I would like to remind you that our comments today will include forward-looking statements, including statements regarding future sales, operating results, and cash balance growth, future margins and expenses, our product portfolios, and expected market sizes for our products. These expectations are subject to risks and uncertainties, and actual results may differ materially from those anticipated due to many factors, including competition, access to customers, the reimbursement environment, unforeseen circumstances, and delays. Additional fac...

More from Mimedx Group, Inc